Spectrum Pharmaceuticals Inc. (SPPI) Starts Presentation at B. Riley Conference
Spectrum Pharmaceuticals (NASDAQ: SPPI) is a biopharmaceutical company focused on acquiring, developing and commercializing novel and targeted drug products, with a primary focus in hematology and oncology. Spectrum has a strong track record of successfully executing across the biopharmaceutical business model, from in-licensing and acquiring differentiated drugs, clinically developing novel assets, successfully gaining regulatory approvals and commercializing in a competitive healthcare marketplace. Spectrum has a late-stage pipeline with novel assets that serve areas of unmet need. This pipeline has the potential to transform the company in the near future. For more information, visit the company's website at www.sppirx.com. About NetworkNewsWire…







